I

InterCure Ltd
NASDAQ:INCR

Watchlist Manager
InterCure Ltd
NASDAQ:INCR
Watchlist
Price: 1.345 USD -6.6% Market Closed
Market Cap: 61.3m USD
Have any thoughts about
InterCure Ltd?
Write Note

Wall Street
Price Targets

INCR Price Targets Summary
InterCure Ltd

There are no price targets for INCR.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
InterCure Ltd Competitors:
Price Targets
688321
Shenzhen Chipscreen Biosciences Co Ltd
31% Upside
4016
Middle East Pharmaceutical Industries Company SJSC
10% Upside
NOVN
Novartis AG
14% Upside
600422
KPC Pharmaceuticals Inc
45% Upside
4886
ASKA Pharmaceutical Holdings Co Ltd
18% Upside
002294
Shenzhen Salubris Pharmaceuticals Co Ltd
18% Upside
2070
Saudi Pharmaceutical Industries and Medical Appliances Corporation SJSC
25% Upside
600332
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
10% Downside

Revenue
Forecast

Revenue Estimate
InterCure Ltd

The compound annual growth rate of InterCure Ltd's revenue for the next 3 years is 17%.

N/A
Past Growth
17%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
InterCure Ltd

The compound annual growth rate of InterCure Ltd's operating income for the next 3 years is 40%.

N/A
Past Growth
40%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
InterCure Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is INCR's stock price target?
Not Available

INCR doesn't have any price targets made by Wall Street professionals.

What is InterCure Ltd's Revenue forecast?
Projected CAGR
17%

The compound annual growth rate of InterCure Ltd's revenue for the next 3 years is 17%.

What is InterCure Ltd's Operating Income forecast?
Projected CAGR
40%

The compound annual growth rate of InterCure Ltd's operating income for the next 3 years is 40%.

Back to Top